Mode
Text Size
Log in / Sign up
N/A Completed N=150 Randomized Supportive Care

Traditional vs Oral Fluid Management in Total Knee Arthroplasty

Arthroplasty, Replacement, Knee
Source: ClinicalTrials.gov NCT03719378 ↗
Enrolled (actual)
150
Serious AEs
0.8%
Results posted
Mar 2021
Primary outcomePrimary: Body Weight — -1.9; -1.6 pounds

Summary

Purpose: Evidence-based guidelines on optimal perioperative fluid management have not been established in patients undergoing orthopaedic surgery. Recent randomized trials in major abdominal surgery suggest that large amounts of IV fluid may increase morbidity and hospital stay. This study will investigate the effects of two regimens of intraoperative fluid management ("traditional" vs. "oral") with physiologic and patient function as primary outcome measures after surgery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Body Weight
-1.9; -1.6
SECONDARY
Knee Range of Motion
-30.5; -26.7; -27.9; -25.5; -7.7; -4.8
SECONDARY
Leg Anthropometric (Girth) Measurements
2.5; 2.1; 0.9; 1.6; 0.00; 0.00
SECONDARY
Number of Participants With Requiring Transfusions
0; 1
SECONDARY
Number of Participants With Off Wound Complications Post Operative
0; 0
SECONDARY
Number of Participants With Thromboembolic Disease
1; 0
SECONDARY
Quadriceps Strength Measure With a Handheld Dynamometer
-10.4; -11.2; -9.0; -9.6; -3.2; -3.8
SECONDARY
Time up and GO
4.4; 3.3; -4.7; -4.0
SECONDARY
30 Second STS Test
-5.3; -4.4; -0.4; 0.3
SECONDARY
Length of the Hospitalization
56; 63; 9; 2
SECONDARY
Number of Patients Re-admitted Post TKA
1; 0
SECONDARY
Postoperative Pain Assessment Using Visual Analog Scale
2.6; 2.3; 4.4; 4.5; 4.3; 4.1
SECONDARY
PONV (Post-operative Nausea and Vomiting)
51; 46; 9; 12; 3; 3
SECONDARY
Veterans Rand -12
-4.7; -1.2; -8.3; -4.5; -2.5; -3.2
SECONDARY
Patient Reported Outcomes - Knee Injury and Osteoarthritis Outcome Score (KOOS)
-1.6; 3.1; 9.4; 12.3
SECONDARY
Patient Reported Outcomes - Knee Society Score(KSS)
-14.6; -0.2; 31.9; 40.5
SECONDARY
Total IV Fluids Received
3895; 350
SECONDARY
Bioimpedence
-17.8; 4.2; -41.4; -38.5; -30.9; -31.0

Eligibility Criteria

Inclusion Criteria

  • Patients between the ages of 18-75 years old undergoing a primary total knee arthroplasty for a diagnosis of degenerative osteoarthritis who do not meet the exclusion criteria listed below

Exclusion Criteria

  • Volume-dependent cardiac conditions:
  • Aortic stenosis
  • Pulmonary valve stenosis
  • Subaortic stenosis
  • Severe Aortic Insufficiency
  • Chronic systolic heart failure
  • Eisenmeinger Syndrome
  • Severe pulmonary HTN
  • Chronic or paroxysmal dysrhythmias
  • Pre-operative electrolyte abnormalities
  • Abnormalities of the HPA (hypothalamic-pituitary axis)
  • Stage 3 Chronic Kidney Disease (or worse)
  • Patients taking angiotensin receptor blockers (ARB)
  • Patients with uncontrolled diabetes mellitus (patient with A1C of 7+ or on insulin)
  • Patients whose BMI is > 35 38 or < 19
  • Current use of long acting narcotic medication or 3 or more months of daily short acting narcotic medication
  • Patients at risk for electrolyte abnormalities, dehydration or intra-operative hypotension. (patients taking angiotensin receptor blockers, ACE inhibitors (48 hours prior to surgery) and Diuretics)
  • Patients with severe, untreated or uncontrolled GERD.
  • Patients that cannot receive spinal anesthesia (e.g. patient with back fusions)
  • Pre-Operative Anemia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03719378). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search